The Leader in Funding MPD Research
The MPD Foundation funds innovative, accountable research that produces results for patients with polycythemia vera, essential thrombocythemia and myelofibrosis. Founded by patients, for patients, we have strong relationships with top researchers, clinicians and biopharmaceutical companies to ensure progress is being made to get us closer to a cure. Terms on every research grant are negotiated to maximize the dollars invested in actual research.
Get the Latest MPD Information
Register for our newsletter now and receive the most up-to-date news on research, alliances, and grants for myeloproliferative disorders.
Incyte to test drug in PV patients
Annette De Bow begins her Trek for a Cure for Myeloproliferative Disorders this week
Sanofi-Aventis purchases TargeGen, maker of JAK2 inhibitor TG101348
Read what our researchers are doing to find a cure in our State of Research update. Enter your full name and e-mail to download it now.


Learn more about the Jaclyn Mason Fund